Intense study - A phase IIIb/IV randomized, controlled study evaluating an intensification treatment strategy of adding enfuvirtide ENF to an oral Highly Active AntiRetroviral Therapy HAART in treatment experienced patients

INTERVENTION: Trade Name: FUZEON*SC 60FL POLV+60FLSOL+60 Pharmaceutical Form: Powder and solvent for solution for injection Current Sponsor code: Ro 29‐9800 Other descriptive name: ENFUVIRTIDE Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 108‐ CONDITION: Treatment of HIV‐1/AIDS. ; MedDRA version: 6.1 Level: PT Classification code 10000807 PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range